- Pharsight Invited To Present On HIV Modeling And Simulation At ASCPT Annual Meeting By : Health News
Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting......... - How HIV Turns Food-Poisoning Into Lethal Infection By : Health News
Nearly half of all HIV-positive African adults who become infected with Salmonella die from what otherwise would be a seven-day bout of diarrhea. - EBCA Teams Up With Partners And Companies To Achieve HIV/AIDS Results In 100 Days, Ethiopia By : Health News
In a first of its kind for Ethiopia, the Ethiopian Business Coalition against HIV/AIDS (EBCA) in partnership with the World Bank Institute has teamed up with the Rapid Results Institute for a pilot project to accelerate the achievement of HIV/AIDS results in Ethiopian companies and deepen the impact of their actions. - Thailand Recording High Number Of New HIV/AIDS Cases, Survey Says By : Health News
Thailand is recording a high number of new HIV/AIDS cases, primarily because of the prevalence of high-risk sexual activities in the country....... - NeurogesX Announces Preliminary Results From Second Phase 3 Clinical Trial In HIV DSP By : Health News
NeurogesX, Inc. a biopharmaceutical company focused on developing and commercializing novel pain management therapies............ - Scientists Devise Approach That Stops HIV At Earliest Stage Of Infection By : Health News
Their study, which appears this week in the online Early Edition of the Proceedings of the National Academy of Sciences (PNAS)........... - Successful Launch TTC/AIC HIV SMS Quiz Program In Mbarara, Uganda By : Health News
The start of the TTC SMS quiz Programme for supporting HIV/AIDS sensitization and education has been incredibly successful. - Anti HIV Gel Proven Safe, Tolerable For Women By : Health News
An experimental anti-HIV gel is safe for women to use on a daily basis.......... - GeoVax Vaccine Only 5th AIDS Vaccine Moving To Phase 2 Human Trials By : Health News
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), http://www.geovax.com, an Atlanta based biotechnology company............ - Anyware Mobile Solutions Helps Geneva Global Fight HIV/AIDS In Africa By : Health News
Geneva Global, the world's leading international philanthropic adviser......... - Anyware Mobile Solutions Helps Geneva Global Fight HIV/AIDS In Africa By : Health News
Geneva Global, the world's leading international philanthropic adviser......... - Lack Of Political Will And The Subordination Of Women Are Major Barriers To Tackling AIDS By : Health News
Denial, myths, complacency, lack of political will and the subordination of women are major obstacles in the fight against HIV and AIDS. - Breaking Down Barriers: A Woman's Path To Reducing HIV Stigma In The Arab American Community By : Health News
HIV/AIDS is still a taboo topic among many Arab Americans, but one determined woman is working hard to change this. - Imitating Monkey's 'jumping Genes' Could Lead To New Treatments For HIV By : Health News
UCL (University College London) scientists have taken a significant step in understanding how retroviruses such as HIV can move between species and the biological mechanisms behind the 'jumping genes' which make some monkeys immune. - Protein In Tick Saliva Prevents HIV-1 From Attaching To T Cells By : Health News
The HIV-1 virus cripples the human immune system by targeting white blood cells called T cells that form the body's first line of defense in fighting infections. - Castle Study Shows Boosted Reyataz(R) (Atazanavir) Is A Well Tolerated And Effective Option By : Health News
The week-48 results of the CASTLE study were announced at the 15th Conference on Retroviruses and Opportunistic Infections (CROI) and showed boosted atazanavir to be as efficacious in antiretroviral-naive HIV-1 patients as lopinavir/ritonavir. - Genetic Immunity Presents Clinical Data On DermaVir Patch Immune Therapy At 15th Annual Conference By : Health News
Genetic Immunity, a US/Hungarian clinical-stage biopharmaceutical company focusing on the development of its patented immunotherapeutic platform technology, announced clinical safety and immunogenicity data on its DermaVir Patch, a topically administered HIV immune therapy. - New Cellular Receptor For HIV Identifed By : Health News
A cellular protein that helps guide immune cells to the gut has been newly identified as a target of HIV when the virus begins its assault on the body's immune system......... - Merck's ISENTRESS® Tablets In Combination With Other Anti HIV Medicines Maintained Reductions By : Health News
SENTRESS® (raltegravir) tablets, Merck's HIV integrase inhibitor, in combination with other anti-HIV medicines......... - GeoVax Labs, Inc.'s Promising HIV/AIDS Vaccine Trial Data Presented At Retrovirus Conference By : Health News
Dr. Harriet Robinson, lead scientist and co-founder of GeoVax Labs, Inc., (OTC Bulletin Board: GOVX) an Atlanta-based biotechnology company developing HIV/AIDS vaccines.......... - New 48-Week Efficacy And Safety Data Presented For INTELENCE(TM) (etravirine) As Part Of HIV By : Health News
New data showed that at 48 weeks, significantly more treatment-experienced adults with HIV-1 with documented........... - Minnesota AIDS Project Recognizes Eighth Annual National Black HIV/AIDS Awareness Day By : Health News
HIV remains a serious public health issue in the United States and in Minnesota. - Antiretroviral Therapy And Sexual Transmission Of HIV By : Health News
Following the recent publication of an article on antiretroviral treatment and sexual transmission of HIV in the Swiss medical journal 'Bulletin des médecins suisses'.......... - Recombination In Lion Feline Immunodeficiency Virus By : Health News
Parts of feline immunodeficiency virus (FIV) isolated from wild lions have undergone substantial genetic recombination, says research published in the online open access journal BMC Genomics. - Breast Feeding Now Safer For Infants Of HIV Infected Mothers By : Health News
First solid evidence that viral transmission through breast milk can be prevented by a drug (Oral presentation #43, Rooms #302-304, Hynes Convention Center, Boston, Mass.) - DHHS Guidelines Support Use Of Trofile(TM) Assay Prior To CCR5 Inhibitor Use By : Health News
Monogram Biosciences, Inc. (Nasdaq: MGRM) announced that guidelines issued by the Department of Health and Human Services (DHHS) recommend that a co-receptor tropism test........... - DHHS Guidelines Support Use Of Trofile(TM) Assay Prior To CCR5 Inhibitor Use By : Health News
Monogram Biosciences, Inc. (Nasdaq: MGRM) announced that guidelines issued by the Department of Health and Human Services (DHHS) recommend that a co-receptor tropism test........... - DHHS Guidelines Support Use Of Trofile(TM) Assay Prior To CCR5 Inhibitor Use By : Health News
Monogram Biosciences, Inc. (Nasdaq: MGRM) announced that guidelines issued by the Department of Health and Human Services (DHHS) recommend that a co-receptor tropism test.......... - AAHIVM Encouraged By TMC125 Approval By : Health News
The American Academy of HIV Medicine (AAHIVM), a national organization of HIV-treating physicians.......... - Research Using Thermo Fisher Scientific RNA Interference Technology Unveils Potential By : Health News
Thermo Fisher Scientific Inc., the world leader in serving science, announced that its RNA-interference (RNAi) technology has enabled a groundbreaking study at Harvard Medical School in Boston.......... - Roche Diagnostics, a World Leader in HIV Monitoring Tests, and ARK Diagnostics, Inc. Sign Letter By : Health News
ARK Diagnostics, Inc. (“ARK”), and Roche Diagnostics signed a letter of intent to negotiate a collaboration agreement that would grant Roche distribution and commercialization rights for ARK’s anti-HIV drug monitoring products.... - Calypte Recognizes World AIDS Day with Product Donation By : Health News
Calypte Biomedical Corporation (OTCBB: CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, announced today that, in honor of World AIDS Day, it has donated 4,000 Aware™ HIV-1/2 OMT (oral fluid) tests to the National AIDS Control Council (NACC) of the Republic of Kenya, in conjunction with its distributor in Kenya, Ultralab & Allied Services Ltd......... - Canopus BioPharma Selected to Present its Drug Candidate for HIV/AIDS Treatment at the Global Summit By : Health News
Canopus BioPharma, Inc. (OTCPK:CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, radiation sickness, cancer, and addiction, announced today that its President Len Rothstein presented at the Global Summit on AIDS and the Church, which was held from November 28-30, 2007...... - Kaiser Permanente Announces $1.3 Million in Grants for HIV/AIDS Services By : Health News
Kaiser Permanente recently announced more than $1.3 million in statewide community benefit grants to help 74 organizations promote HIV/AIDS awareness, prevention, screening, support and treatment for people living with the disease........ - Data from STEP Study Presented at Open Scientific Session Confirm Merck's Investigational HIV By : Health News
In the STEP study, one of two phase II trials of Merck & Co., Inc.'s investigational HIV vaccine (V520), the vaccine was not effective at either preventing infection in volunteers not previously infected with HIV or at reducing viral loads in those study volunteers who became infected with HIV during the trial......... - YourTechOnline.com Leads Effort to Provide Technical Support for HIV/AIDS Treatment and Prevention By : Health News
YourTechOnline.com Inc, PC Magazine Editors’ Choice award-winning provider of 24-hour-a-day online technical support, announces its plan to bring technical support and infrastructure advancement to the HIV/AIDS relief and child education crisis in Africa... - Global Fund Approves $1B In New Grants By : Health News
The board of the Global Fund To Fight AIDS, Tuberculosis and Malaria on Monday announced that it has approved 73 new grants worth $1.1 billion over the next two years, the AFP/Yahoo! Health reports. - Global Fund Approves $1B In New Grants By : Health News
The board of the Global Fund To Fight AIDS, Tuberculosis and Malaria on Monday announced that it has approved 73 new grants worth $1.1 billion over the next two years, the AFP/Yahoo! Health reports. - Global Fund Approves $1B In New Grants By : Health News
The board of the Global Fund To Fight AIDS, Tuberculosis and Malaria on Monday announced that it has approved 73 new grants worth $1.1 billion over the next two years, the AFP/Yahoo! Health reports. - Study Analyzes Antiretroviral Drug Production, Cost Policies Of Brazil By : Health News
"Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment," PLoS Medicine: The study, conducted by Amy Nunn of the Harvard School of Public Health and colleagues, analyzes the costs of individual antiretroviral drugs in Brazil............ - City of West Hollywood, HANSON and Tom’s Shoes Will Join Together to Fight Poverty and HIV/AIDS in By : HIV - AIDS News
The City of West Hollywood, recording artists HANSON and TOMS Shoes will join together to help fight poverty and HIV/AIDS in Africa. The partnership is a component of the City’s “Global AIDS Initiative” which was created with the goal of advocating for and supporting education, outreach and funding efforts to combat the AIDS pandemic in Africa...... - AIDS Drugs In Brazil By : Health News
Brazil's strategy of negotiating AIDS drug prices with multinational pharmaceutical companies and producing generic AIDS drugs locally saved that country's AIDS program approximately 1 billion US dollars between 2001 and 2005, according to research published in PLoS Medicine. - Curbing HIV In Teens Requires Early Routine Testing By : Health News
Half of all new HIV infections in the United States occur among 13 to 24 year olds, but adolescents rarely seek HIV testing. - HIV Drug Resistance Risk In Mothers Reduced By Combination Of Common Drugs By : Health News
New research from the University of Alabama at Birmingham (UAB) shows that adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs............. - Combination Of Common Drugs Reduces Risk Of HIV Drug Resistance In Mothers By : Health News
New research from the University of Alabama at Birmingham (UAB) shows that adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options. - The Impact Of HIV In Central America: The United Nations Report By : Health News
United Nations agencies and programs are committed to taking all the necessary measures to intensify Central America's response to the HIV epidemic. - Ohio Not Applying For Federal Funds Aimed At Preventing HIV Among Teenagers By : Health News
Officials at the Ohio Department of Education are not applying for a $1.25 million, five-year grant from CDC intended to prevent the spread of HIV among teenagers, the Cleveland Plain Dealer reports. - POZ Examines HIV/AIDS In U.S. South By : Health News
POZ in its November issue examined HIV/AIDS in the U.S. South. The South -- which includes 16 states and Washington, D.C. -- accounts for 45% of new U.S. HIV cases and 50% of all AIDS-related deaths, according to CDC. - Novel Antiviral HIV Drug SpirH™ Offers New Hope for AIDS Patients Worldwide By : Health News
Canopus BioPharma, Inc. (OTC: CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, radiation sickness, cancer, and addiction, announced today the commencement of a 30 patient Phase II clinical trial for its new HIV-1 anti-viral therapy, SpirH™. SpirH™ is being studied to determine its potential to delay the onset of full-blown AIDS when used as a mono-therapy in early stage infection...... - Some HIV-Positive People Taking Longer To Initiate Treatment, Study Says By : Health News
Some HIV-positive people in key demographic groups do not seek treatment any sooner than they did in the past, and some people now take longer to initiate treatment, according to a study published in the Nov. 15 issue of Clinical Infectious Diseases, United Press International reports (United Press International, 10/27). - UPDATE: FDA Approves ISENTRESSTM (raltegravir) Tablets, First-in-Class Oral HIV-1 Integrase Inhibito By : HIV - AIDS News
Merck & Co., Inc., announced today that the U.S. Food and Drug Administration (FDA) granted ISENTRESSTM (raltegravir) tablets accelerated approval for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents. - OraSure Technologies and the Latino Commission on AIDS Launch HIV Testing Initiative By : Health News
OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics, today announced the launch of a Rapid HIV Testing Initiative in connection with National Latino Awareness Day 2007. This Initiative is being conducted in partnership with the Latino Commission on AIDS with support from the Congressional Hispanic Caucus........ - Groups Calling On U.S. Presidential Candidates To Commit To Fight Against HIV/AIDS By : Health News
The Global AIDS Alliance Fund and other groups are calling on U.S. presidential candidates to sign a pledge to commit to the fight against HIV/AIDS domestically and worldwide, the Keene Sentinel reports. The pledge also calls on candidates to commit $50 billion to such efforts. - HIV Linked To Increased Risk Of ESRD In African Americans By : Health News
For African Americans infected with HIV, the risk of end-stage renal disease (ESRD) is six times higher than for whites with HIV and similar to the ESRD risk associated with diabetes, reports a study in the November Journal of the American Society of Nephrology. - FDA Approves New HIV Drug - Raltegravir Tablets Used In Combination With Other Antiretroviral By : Health News
The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents. - FDA Approves Merck's Antiretroviral Raltegravir By : Health News
Merck on Friday announced that FDA has approved its antiretroviral drug raltegravir for use by HIV-positive people who have not responded to other treatments, the Wall Street Journal reports (Corbett Dooren, Wall Street Journal, 10/12). - Cytheris Expands Interleukin-7 Clinical Development Program With International Phase I/IIa Trial By : Health News
Cytheris, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced expansion of the clinical trial program for CYT107, the company’s recombinant human Interleukin-7 (IL-7), with the initiation of a Phase I/IIa clinical trial in HIV patients..... . - New HIV Cases Increasing In Australia, Report Says By : Health News
The number of newly diagnosed HIV cases in Australia has increased by about one-third during the past few years, according to a report released Wednesday by the National Centre in HIV Epidemiology and Clinical Research, the Sydney Morning Herald reports. - Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational By : Health News
Vaccination in a phase II clinical trial of Merck & Co., Inc.'s investigational HIV vaccine (V520) is being discontinued because the vaccine was not effective. The announcement was made today by the co-sponsors of this clinical trial, Merck & Co., Inc., and the HIV Vaccine Trials Network (HVTN), which is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health. - About Two-Thirds Of HIV-Positive People In U.S. Overweight, Obese, Study Says By : Health News
About two-thirds of HIV-positive people in the U.S. might be overweight or obese, "mirroring" the total U.S. population, according to a study released Thursday at the 45th Annual Meeting of the Infectious Diseases Society of America in San Diego, the AP/Los Angeles Times reports. - Deep Frozen HIV Specimens By : Health News
The development of an HIV vaccine is hindered by the rapidity with which the virus mutates. - FDA Advisory Committee Unanimously Recommends Accelerated Approval of ISENTRESS™ (raltegravir) By : Health News
Merck & Co., Inc. announced today that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted unanimously to recommend accelerated FDA approval of ISENTRESS™ (raltegravir) in combination with other antiretroviral therapy (ART) for the treatment of HIV infection in treatment-experienced patients with ongoing viral replication despite existing therapy. - U.S. Faces 'Ocean Of Need' In Combating HIV/AIDS In Africa, Opinion Piece Says By : Health News
Global efforts to treat HIV-positive people in Africa have increased "massively," but there is still "an ocean of need," Washington Post columnist Michael Gerson writes in an opinion piece. - Washington, D.C., Community Groups Return 70,000 Condoms Given Away In City-Wide Program By : Health News
Community groups in Washington, D.C., last week returned up to 70,000 of the condoms given away earlier this year as part of a city program that aims to reduce the spread of HIV and other sexually transmitted infections, the AP/Google.com reports. - 23 States, Cities Receive $35M In CDC Grants To Increase HIV Testing Among Blacks By : Health News
CDC on Thursday announced that 23 states and large cities with large populations of blacks affected by HIV/AIDS will receive $35 million in grants to expand HIV testing, CQ HealthBeat reports. - Nigerian Labor Minister Says Government Will Not Tolerate Discrimination Against HIV-Positive Worker By : Health News
Nigerian Labor Minister Hassan Muhammad Lawal on Monday at the Africa-Middle East Regional HIV/AIDS and Wellness Conference said his country's government would not tolerate discrimination against HIV-positive workers, Nigeria's Daily Trust reports (Gulloma, Daily Trust, 9/25). - BusinessWeek Profiles Microsoft Researchers Using Spam-Blocking Software To Develop HIV Vaccines By : Health News
BusinessWeek in its Oct. 1 edition profiled researchers at Microsoft who are refocusing spam-blocking technology to locate HIV-infected cells to help produce vaccines. - Halt Of Merck's HIV Vaccine Trial Should Not 'Slow Progress' Toward Future Vaccine Development By : Health News
Although many people "felt robbed" by the announcement last week that Merck's trial of an experimental HIV vaccine had been halted, it would be "worse [to] allow the news to slow progress" toward development of future HIV vaccines, Seth Berkley, president and CEO of the International AIDS Vaccine Initiative, writes in a Los Angeles Times opinion piece (Berkley, Los Angeles Times, 9/27). - Halt Of Merck's HIV Vaccine Trial Should Not 'Slow Progress' Toward Future Vaccine Development By : Health News
Although many people "felt robbed" by the announcement last week that Merck's trial of an experimental HIV vaccine had been halted, it would be "worse [to] allow the news to slow progress" toward development of future HIV vaccines, Seth Berkley, president and CEO of the International AIDS Vaccine Initiative, writes in a Los Angeles Times opinion piece (Berkley, Los Angeles Times, 9/27). - Mozambique Archbishop Chimoio Says European-Made Condoms, Antiretrovirals Tainted With HIV By : Health News
Archbishop Francisco Chimoio, the head of the Roman Catholic Church in Mozambique, on Wednesday said that two European countries are manufacturing condoms that deliberately have been tainted with HIV as part of a plan to "colonize the continent," Reuters reports. - Over 80% of Patients on ATC Achieve Undetectable HIV After 24 Weeks By : Health News
Melbourne-based biotechnology company Avexa Limited (ASX:AVX) announced today positive 24 week data from the phase 2b clinical trial of apricitabine (ATC). The data demonstrate that, in over 80% of patients treated with ATC, the level of HIV in the blood was reduced to below detectable levels after 24 weeks. This was markedly better than those patients on the 3TC control..... - GenVec Announces Increased Funding for FMD Vaccine Program from the U.S. Department of Homeland By : Health News
GenVec, Inc. (Nasdaq:GNVC) announced today that it has executed the first option period from the previously announced agreement with the U.S. Department of Homeland Security (DHS) that will provide $5.6 million over the next 12 months to support the development of vaccines for the prevention of foot-and-mouth disease (FMD)..... - Globe And Mail Examines New Methods For Screening Volunteers For HIV Vaccine By : Health News
Toronto's Globe and Mail on Thursday examined efforts to develop new measurements for screening the blood of volunteers in Africa for vaccine trials for HIV/AIDS.............. - PrEP Could Prevent About Three Million HIV Cases In Sub-Saharan Africa Over 10 Years, Study Says By : Health News
Pre-exposure prophylaxis -- the practice of HIV-negative people taking antiretroviral drugs before potential exposure to the virus -- could prevent as many as three million new HIV cases over 10 years in sub-Saharan Africa........... - Group In Zimbabwe Works To Fight Poverty, Empower Girls To Reduce Spread Of HIV, Reuters Reports By : Health News
Zimbabwe-based Girl Child Network, which organizes girls' clubs in towns and villages, is focusing on combating poverty in the country to empower girls, reduce the incidence of rape and fight the spread of HIV, Reuters reports. - Spanish Health Ministry Announces Plan To Determine Number Of HIV Cases By 2015 By : Health News
The Spanish Ministry of Health recently announced a new plan to determine the number of people living with HIV in the country and reduce the spread of the virus by 2015, El Pais reports. - Etubics Reports Breakthrough Next Generation HIV Vaccine at AIDS Conference By : Health News
At the AIDS Vaccine 2007 Conference today, Etubics Corporation reported on a novel adenovirus vector vaccine that can boost the HIV/AIDS virus immune response and deliver vaccination against a second disease at the same time..... - Encouraging Phase II Data on HIV Vaccine Utilizing GenVec Technologies Presented at Seattle AIDS By : Health News
GenVec, Inc. (Nasdaq:GNVC) announced that results from multiple ongoing clinical trials utilizing its adenovector vaccine technologies were presented yesterday at the AIDS Vaccine 2007 Conference taking place in Seattle, Washington this week. The trials, which are investigating a DNA prime- adenoviral vector boost strategy, incorporate a multiclade rAd5 HIV- 1 vaccine developed by GenVec in collaboration with the Vaccine Research Center (“VRC”), National Institute of Allergy and Infectious...... - Discovery Of HIV's Strategy For Multiplying In White Blood Cells By : Health News
The AIDS virus (HIV) attacks immune system cells and once inside them it multiplies. - Transplants For HIV Positive Patients? By : Health News
Not long ago, organ transplantation was not considered an option for HIV infected patients. - Grant Aided Training Program To Reduce AIDS Among India's Adolescents By : Health News
The University of South Florida's global health initiative to help India build an infrastructure to fight AIDS............ - Pregnancy May Help Cut Risks For HIV Infected Women By : Health News
Women with HIV infection who become pregnant have a lower risk of progression to AIDS and death............ - New York City Records Increasing Number Of HIV Cases Among MSM Younger Than Age 30 By : Health News
The New York City Department of Health and Mental Hygiene on Tuesday reported that new HIV diagnoses among men who have sex with men younger than age 30 has increased by 33% since 2001, the New York Times reports. - Sexual Behavior Does Not Explain Varying HIV Rates Among Gay And Straight Men By : Health News
It has been suggested that US gay men have higher rates of HIV infection in comparison to US straight men because of differences in sexual behaviors. - Organizations Partner to Build Center for Women and Children in Africa By : Health News
Gethsemani Circle of Friends, a North Charleston nonprofit organization and the Family Services Research Center at the Medical University of South Carolina (MUSC) are partnering with Nkabom Artist and Craftspeople Association of Accra, Ghana to build a center in Okurase, Ghana that will provide arts-based skills training and formal education for the community and improve the lives of women and children impacted by HIV/AIDS..... - Understanding How Antibodies Fight HIV May Further Efforts To Create AIDS Vaccine By : Health News
By furthering scientists' understanding of the molecular mechanisms that separate the minority of successful HIV antibodies from the majority of ineffective antibodies................ - New Insights Into HIV Disease Complexity By : Health News
Three related papers published in the Sept. 1 edition of The Journal of Immunology provide key new insights into the complexity of HIV/AIDS. - HIV Patients With Declining Platelet Counts Have Raised Risk For Dementia By : Health News
An HIV patient whose platelet counts (the number of clotting cells in the blood) are declining is probably more likely to suffer from HIV-associated dementia........... - Vietnamese City To Launch Methadone Program To Reduce Spread Of HIV Among IDUs By : Health News
Health officials in Ho Chi Minh City, Vietnam, plan to launch a methadone program modeled after one in Hong Kong in an effort to reduce the spread of HIV among injection drug users.............. - ABC Examines Shortage Of Medical Workers To Provide HIV-Positive Children In Lesotho With Treatment By : Health News
ABC's "World News" on Monday examined how a physician shortage in Lesotho is hindering efforts to provide HIV-positive children in the country with treatment. - FDA Releases Review Of Merck's Antiretroviral Raltegravir Ahead Of Panel Meeting By : Health News
FDA on Friday released a review of Merck's experimental antiretroviral drug raltegravir ahead of a panel meeting, scheduled for Wednesday, to determine whether the drug should be approved, the Wall Street Journal reports (Corbett Dooren, Wall Street Journal, 8/31). - HIV/AIDS In Papua New Guinea Could Mirror African Epidemic, U.N. Says By : Health News
HIV/AIDS in Papua New Guinea could reflect the situation in Africa because new cases are increasing and more than 75% of people living with the virus are unable to access antiretroviral drugs, the United Nations said recently, Bloomberg reports. - Many HIV Patients Think They Are Stigmatized By Health Care Workers By : Health News
Physicians might want to be extra careful about how they treat HIV-infected patients -- not just in the clinical sense but in the way they behave toward them. - Books Accuse UNAIDS Of Inflating HIV Prevalence Estimates To Increase Donor Funding By : Health News
UNAIDS in two recently published books has "come under stinging attack" and been accused of "allowing politics to trump science in its efforts to combat" HIV/AIDS, AFP/Yahoo! News reports. - Compliance And Viral Suppression Improved In HIV Patients Using Pill Box Organizers By : Health News
Inexpensive pill box organizers are an easy, successful, and cost-effective tool to help patients take their medications as prescribed............ - UNICEF Launches $500,000 Program In Zimbabwe To Train Teachers To Provide HIV Education By : Health News
UNICEF on Monday launched a weeklong, $500,000 program in Zimbabwe aimed at training 1,500 primary and secondary teachers on how to provide HIV prevention education, UN News Service reports. - Donation From Wellcome Trust Boosts HIV Research In Sub-Saharan Africa By : Health News
The Africa Centre for Health and Population Studies, based in an area of South Africa where over one in five people are HIV infected............. - Humanitarian Groups Forge Medical Supply Pipeline for AIDS Patients in South Africa By : Health News
The Foundation for Hospices in Sub-Saharan Africa, in collaboration with Direct Relief International, is launching a supply chain program to get hospice and palliative care supplies to HIV/AIDS patients in the Eastern Cape of South Africa. - Rights Groups Call On Homeland Security Department To Investigate Death Of HIV-Positive Person By : Health News
The American Civil Liberties Union of Southern California and Human Rights Watch in a letter sent on Monday to the Department of Homeland Security's Office of Inspector General called on the department to investigate the death of an HIV-positive inmate at a San Pedro, Calif., immigration detention center............. - Zambia's HIV/AIDS Council Director Urges People To Be Tested On National Voluntary Counseling By : Health News
Alex Simwanza, director of programs for Zambia's National HIV/AIDS Council..............
|
